Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
medicxi
4
×
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
biotech
boston blog main
cancer
deals
eli lilly
new york blog main
startups
avalon ventures
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
correlation ventures
detroit blog main
detroit top stories
drugs
duchenne muscular dystrophy
fda
glaxosmithkline
incyte
indiana blog main
indiana top stories
innovation
jennifer doudna
laura shawver
national
new york top stories
orbimed
ra capital management
raleigh-durham blog main
raleigh-durham top stories
san diego
san francisco top stories
What
advance
bio
biology
crispr
cytokine
drugs
enhanced
new
roundup
san
suite
synthetic
synthorx
alliance
biologic
biopharma
bristol
buy
calls
changing
color
company
congress
congressional
days
demonstrating
diego’s
drug
executives
feud
files
group
growing
hours
initial
ipo
isn’t
known
kudos
later
Language
unset
Current search:
medicxi
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs